Abstract LB-B16: The AKR1C3-Activated Prodrug OBI-3424 Exerts Profound In Vivo Efficacy Against Preclinical Models of T-Cell Acute Lymphoblastic Leukemia (T-ALL); a Pediatric Preclinical Testing Consortium Study
暂无分享,去创建一个
B. Teicher | R. Lock | Malcolm A. Smith | Jianxin Duan | R. Yung | Tara Pritchard | K. Evans | Yuelong Guo | S. Erickson